CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya
收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23
Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yin, Rutie;  Li, Ning;  Wu, Lingying;  Wang, Jing;  Zhu, Jianqing
收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
收藏  |  浏览/下载：32/0  |  提交时间：2022/05/05
Investigating Historical Baseflow Characteristics and Variations in the Upper Yellow River Basin, China 期刊论文
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 卷号: 19, 期号: 15
作者:  Zhao, Guizhang;  Kong, Lingying;  Li, Yunliang;  Xu, Yuanzhi;  Li, Zhiping
收藏  |  浏览/下载：1/0  |  提交时间：2023/12/19
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling
收藏  |  浏览/下载：45/0  |  提交时间：2021/11/01
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin
收藏  |  浏览/下载：42/0  |  提交时间：2021/11/01
Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10
Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载：26/0  |  提交时间：2022/01/10
M1-TO-M2 PHENOTYPE SHIFT OF MACROPHAGES IN VASCULAR TISSUE OF TAKAYASU ARTERITIS 会议论文
作者:  Kong, Xiufang;  Xu, Ming;  Cui, Xiaomeng;  Ma, Lingying;  Chen, Huiyong
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Wu, Lingying;  Zhu, Jianqing;  Yin, Rutie;  Wu, Xiaohua;  Lou, Ge
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/31

©版权所有 ©2017 CSpace - Powered by CSpace